Effect of Photobiomodulation Therapy on Muscle Function and Inflammation in Persons With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing MSNCT03691766

What it found

No results found

We found no results in the registry or in papers.

This trial finished 7 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Photobiomodulation Therapy

Placebo

  • Placebo

What it measured

Main measures

  • Muscle Fatigue

    up to 4 week photobiomodulation intervention, immediately after the intervention, and then 4 months after this extended treatment

    Fatigue

Other measures (1)

  • Systemic Inflammation

    up to 4 week photobiomodulation intervention, and then again at 4 months post-intervention

    Immune response

Who could take part

Relapsing MS · 20 to 60

Show the full criteria

Inclusion criteria

1. Relapsing remitting MS, 2. Independent or ambulatory with minimal aid. 3. Must be able to move foot (ankle dorsiflexion) at least moderately forcibly against gravity (manual muscle test score 3-5) 4. Subjects must be able to walk for 6 minutes independently with no or minimal use of an assistive device.

Exclusion criteria

1. No noticeable left right ankle strength asymmetry 2. No exacerbations (MS attacks) or immunosuppressive therapy use within the previous 6 months 3. No concurrent infection or known cardiovascular disease including having a pacemaker; or other serious medical co-morbidity including metabolic, mitochondrial, autoimmune, diseases or other co-existing neurologic conditions. 4. Not involved in any clinical trial or other research that could confound results. 5. Must not be pregnant 6. Must not have an active diagnosis of cancer

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis. We will also investigate mechanisms for any improvements.

Loading reviews and guidelines…

History

    1. Started

      Apr 2018

    2. Main results due

      Sept 2019

    3. Finished

      Sept 2019

    Assembled by software from public sources.